Quantum BioPharma News

Quantum BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 13 00:37

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 29 19:33

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 22 19:57

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 21 20:54

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 7 19:33

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 1 00:58

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 16 19:31

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 9 19:40

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 9 18:06

Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 30 21:48

424B5: Prospectus

Aug 28 00:44

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 28 00:44

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 26 18:22

6-K/A: Report of foreign private issuer (related to financial reporting)

Aug 20 05:23

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 17 00:17

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 15 19:12

FSD Pharma | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

Aug 14 18:16

FSD Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 14 18:16

FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 12 18:11

FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 9 19:32